I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for High-flow Nasal
Cannula by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for High-flow Nasal Cannula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for High-flow Nasal Cannula
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Air/Oxygen Blender
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Air/Oxygen Blender by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Air/Oxygen Blender by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Active Humidifier
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Active Humidifier by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Active Humidifier by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Single Heated
Tube by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Single Heated Tube by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Single Heated Tube by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Nasal Cannula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Nasal Cannula by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Nasal Cannula by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other Consumables
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Acute Respiratory
Failure by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Acute Respiratory Failure
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Acute Respiratory
Failure by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Chronic
Obstructive Pulmonary Disease (COPD) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Chronic Obstructive
Pulmonary Disease (COPD) by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Chronic Obstructive
Pulmonary Disease (COPD) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 25: World Current & Future Analysis for Acute Heart
Failure by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Acute Heart Failure by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Acute Heart Failure by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Carbon Monoxide
Toxicity by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Carbon Monoxide Toxicity by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Carbon Monoxide
Toxicity by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 31: World Current & Future Analysis for Sleep Apnea by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Sleep Apnea by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Sleep Apnea by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Bronchiectasis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 35: World Historic Review for Bronchiectasis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Bronchiectasis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 38: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 39: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 40: USA Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for High-flow Nasal Cannula
by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 43: USA Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for High-flow Nasal Cannula
by Application - Percentage Breakdown of Value Sales for Acute
Respiratory Failure, Chronic Obstructive Pulmonary Disease
(COPD), Acute Heart Failure, Carbon Monoxide Toxicity, Sleep
Apnea, Bronchiectasis and Other Applications for the Years
2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for High-flow Nasal
Cannula by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 49: Canada Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for High-flow Nasal
Cannula by Application - Percentage Breakdown of Value Sales
for Acute Respiratory Failure, Chronic Obstructive Pulmonary
Disease (COPD), Acute Heart Failure, Carbon Monoxide Toxicity,
Sleep Apnea, Bronchiectasis and Other Applications for the
Years 2012, 2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for High-flow Nasal Cannula
by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 55: Japan Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for High-flow Nasal Cannula
by Application - Percentage Breakdown of Value Sales for Acute
Respiratory Failure, Chronic Obstructive Pulmonary Disease
(COPD), Acute Heart Failure, Carbon Monoxide Toxicity, Sleep
Apnea, Bronchiectasis and Other Applications for the Years
2012, 2020 & 2027

CHINA
Table 58: China Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for High-flow Nasal Cannula
by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 61: China Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for High-flow Nasal Cannula
by Application - Percentage Breakdown of Value Sales for Acute
Respiratory Failure, Chronic Obstructive Pulmonary Disease
(COPD), Acute Heart Failure, Carbon Monoxide Toxicity, Sleep
Apnea, Bronchiectasis and Other Applications for the Years
2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for High-flow Nasal
Cannula by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 65: Europe Historic Review for High-flow Nasal Cannula by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for High-flow Nasal
Cannula by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for High-flow Nasal
Cannula by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 70: Europe Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for High-flow Nasal
Cannula by Application - Percentage Breakdown of Value Sales
for Acute Respiratory Failure, Chronic Obstructive Pulmonary
Disease (COPD), Acute Heart Failure, Carbon Monoxide Toxicity,
Sleep Apnea, Bronchiectasis and Other Applications for the
Years 2012, 2020 & 2027

FRANCE
Table 73: France Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for High-flow Nasal
Cannula by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 76: France Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for High-flow Nasal
Cannula by Application - Percentage Breakdown of Value Sales
for Acute Respiratory Failure, Chronic Obstructive Pulmonary
Disease (COPD), Acute Heart Failure, Carbon Monoxide Toxicity,
Sleep Apnea, Bronchiectasis and Other Applications for the
Years 2012, 2020 & 2027

GERMANY
Table 79: Germany Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: Germany Historic Review for High-flow Nasal Cannula
by Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: Germany 15-Year Perspective for High-flow Nasal
Cannula by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 82: Germany Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 83: Germany Historic Review for High-flow Nasal Cannula
by Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 84: Germany 15-Year Perspective for High-flow Nasal
Cannula by Application - Percentage Breakdown of Value Sales
for Acute Respiratory Failure, Chronic Obstructive Pulmonary
Disease (COPD), Acute Heart Failure, Carbon Monoxide Toxicity,
Sleep Apnea, Bronchiectasis and Other Applications for the
Years 2012, 2020 & 2027

ITALY
Table 85: Italy Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: Italy Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Italy 15-Year Perspective for High-flow Nasal Cannula
by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 88: Italy Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 89: Italy Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 90: Italy 15-Year Perspective for High-flow Nasal Cannula
by Application - Percentage Breakdown of Value Sales for Acute
Respiratory Failure, Chronic Obstructive Pulmonary Disease
(COPD), Acute Heart Failure, Carbon Monoxide Toxicity, Sleep
Apnea, Bronchiectasis and Other Applications for the Years
2012, 2020 & 2027

UNITED KINGDOM
Table 91: UK Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: UK Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: UK 15-Year Perspective for High-flow Nasal Cannula by
Component - Percentage Breakdown of Value Sales for Air/Oxygen
Blender, Active Humidifier, Single Heated Tube, Nasal Cannula
and Other Consumables for the Years 2012, 2020 & 2027

Table 94: UK Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 95: UK Historic Review for High-flow Nasal Cannula by
Application - Acute Respiratory Failure, Chronic Obstructive
Pulmonary Disease (COPD), Acute Heart Failure, Carbon Monoxide
Toxicity, Sleep Apnea, Bronchiectasis and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 96: UK 15-Year Perspective for High-flow Nasal Cannula by
Application - Percentage Breakdown of Value Sales for Acute
Respiratory Failure, Chronic Obstructive Pulmonary Disease
(COPD), Acute Heart Failure, Carbon Monoxide Toxicity, Sleep
Apnea, Bronchiectasis and Other Applications for the Years
2012, 2020 & 2027

SPAIN
Table 97: Spain Current & Future Analysis for High-flow Nasal
Cannula by Component - Air/Oxygen Blender, Active Humidifier,
Single Heated Tube, Nasal Cannula and Other Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 98: Spain Historic Review for High-flow Nasal Cannula by
Component - Air/Oxygen Blender, Active Humidifier, Single
Heated Tube, Nasal Cannula and Other Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 99: Spain 15-Year Perspective for High-flow Nasal Cannula
by Component - Percentage Breakdown of Value Sales for
Air/Oxygen Blender, Active Humidifier, Single Heated Tube,
Nasal Cannula and Other Consumables for the Years 2012, 2020 &
2027

Table 100: Spain Current & Future Analysis for High-flow Nasal
Cannula by Application - Acute Respiratory Failure, Chronic
Obstructive Pulmonary Disease (COPD), Acute Heart Failure,
Carbon Monoxide Toxicity, Sleep Apnea, Bronchiectasis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 101: Spain Historic Review for High-flow Nasal Cannula by
Application - Acut